Akanda Corp. (AKAN)
NASDAQ: AKAN
· Real-Time Price · USD
3.41
-0.13 (-3.67%)
At close: Sep 05, 2025, 3:59 PM
3.49
2.35%
After-hours: Sep 05, 2025, 06:31 PM EDT
Company Description
Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products in the United Kingdom, Lesotho, and internationally.
It intends to supply cannabis based medical and wellness products.
The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.
Akanda Corp.
| Country | GB |
| IPO Date | Mar 15, 2022 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 46 |
| CEO | Katharyn Field |
Contact Details
Address: 1a, 1b Learoyd Road New Romney, GB | |
| Website | https://www.akandacorp.com |
Stock Details
| Ticker Symbol | AKAN |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001888014 |
| CUSIP Number | 00971M502 |
| ISIN Number | CA00971M5028 |
| Employer ID | 00-0000000 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Katharyn Field | Interim Chief Executive Officer & Executive Director |
| Dr. Gurcharn Deol B.A., M.A., Ph.D. | Chief Financial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 29, 2025 | 6-K | Filing |
| Aug 22, 2025 | 6-K | Filing |
| Aug 22, 2025 | 6-K | Filing |
| Aug 08, 2025 | 6-K | Filing |
| May 01, 2025 | 6-K | Filing |
| Apr 30, 2025 | 20-F | Filing |
| Apr 18, 2025 | 6-K | Filing |
| Apr 16, 2025 | 6-K | Filing |
| Apr 01, 2025 | 6-K | Filing |
| Mar 11, 2025 | 6-K | Filing |